Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken

被引:19
作者
Geris, KL
Hickey, GJ
Berghman, LR
Visser, TJ
Kühn, ER
Darras, VM
机构
[1] Lab Comparat Endocrinol, B-3000 Louvain, Belgium
[2] Merck Res Labs, Rahway, NJ 07065 USA
[3] Lab Neuroendocrinol & Immunol Biotechnol, B-3000 Louvain, Belgium
[4] Erasmus Univ, Sch Med, Dept Internal Med 3, NL-3000 DR Rotterdam, Netherlands
关键词
L-692,429; GH; TRH; SRIH; corticosterone; in vitro; in vivo;
D O I
10.1006/gcen.1998.7102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chickens were used as a model to further analyze the efficacy and specificity of L-692,429, a novel nonpeptidyl mimic of growth hormone (GH)-releasing peptide-6 (GHRP-6), which is a specific GH-releasing secretagogue in mammals. Actions at the level of the pituitary and the hypothalamus were studied. Pituitaries isolated from 1-day-old (Cl) chicks responded in a dose-dependent manner to L-692,429 (ED50 = 10 nM). Using equimolar concentrations of thyrotropin-releasing hormone (TRH), human GH-releasing hormone (hGHRH(1-29)), and L-692,429 (10 nM), L-692,429 had 20-25% the in vitro potency of the two endogenous releasing factors. There was an additive effect between hGHRH(1-29), (10 nM) and L-692,429 (10 or 100 nM) on GH release from C1 pituitaries but no such additive effect was observed when pituitaries were exposed to both TRH (10 nM) and L-692,429 (100 nM). An acute challenge with 50 mu g L-692,429 resulted in increased plasma GH levels within 5 min, which remained elevated for up to 15 min (Cl chickens). This increase in GH was accompanied by a drop in hypothalamic TRH content by 5 min. Hypothalamic somatostatin (SRIH) content did not change. Plasma corticosterone concentrations were increased following L-692,429 treatment, whereas plasma alpha-subunit, T-4, and T-3 levels were unchanged. To confirm the role of the decreased hypothalamic TRH concentrations in the GH-releasing activity of L-692,429 in the chicken, chickens (C1) were pretreated with normal rabbit serum (NRS) or a TRH antiserum (1/50) 1 h prior to the L-692,429 challenge. Both groups showed an increase in circulating GPI but the increase was within 5 min inhibited by the TRH antiserum pretreatment, whereas no differences were noted in plasma corticosterone levels. It is concluded that in the chicken the GH secretagogue L-692,429 has a dual action site: (1) directly at the level of the pituitary and (2) centrally through an increase in hypothalamic TRH release. (C) 1908 Academic Press.
引用
收藏
页码:186 / 196
页数:11
相关论文
共 53 条
  • [1] THE GROWTH-HORMONE SECRETAGOGUE, L-692,429, INDUCES PHOSPHATIDYLINOSITOL HYDROLYSIS AND HORMONE-SECRETION BY HUMAN PITUITARY-TUMORS
    ADAMS, EF
    PETERSEN, B
    LEI, T
    BUCHFELDER, M
    FAHLBUSCH, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (02) : 555 - 561
  • [2] THYROTROPIN-RELEASING HORMONE-INDUCED GROWTH-HORMONE (GH) SECRETION IN ANESTHETIZED CHICKENS - INHIBITION BY GH-RELEASING FACTOR AT CENTRAL SITES
    AHENE, CA
    LEA, RW
    HARVEY, S
    [J]. JOURNAL OF ENDOCRINOLOGY, 1991, 128 (01) : 13 - 19
  • [3] NEUROENDOCRINE RESPONSES TO A NOVEL GROWTH-HORMONE SECRETAGOGUE, L-692,429, IN HEALTHY OLDER SUBJECTS
    ALOI, JA
    GERTZ, BJ
    HARTMAN, ML
    HUHN, WC
    PEZZOLI, SS
    WITTREICH, JM
    KRUPA, DA
    THORNER, MO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) : 943 - 949
  • [4] ROLE OF SELECTED ENDOGENOUS PEPTIDES IN GROWTH HORMONE-RELEASING HEXAPEPTIDE ACTIVITY - ANALYSIS OF GROWTH HORMONE-RELEASING HORMONE, THYROID HORMONE-RELEASING HORMONE, AND GONADOTROPIN-RELEASING-HORMONE
    BERCU, BB
    YANG, SW
    MASUDA, R
    WALKER, RF
    [J]. ENDOCRINOLOGY, 1992, 130 (05) : 2579 - 2586
  • [5] IMMUNOCYTOCHEMICAL DEMONSTRATION OF CHICKEN HYPOPHYSEAL THYROTROPES AND DEVELOPMENT OF A RADIOIMMUNOLOGICAL INDICATOR FOR CHICKEN TSH USING MONOCLONAL AND POLYCLONAL HOMOLOGOUS ANTIBODIES IN A SUBTRACTIVE STRATEGY
    BERGHMAN, LR
    DARRAS, VM
    CHIASSON, RB
    DECUYPERE, E
    KUHN, ER
    BUYSE, J
    VANDESANDE, F
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1993, 92 (02) : 189 - 200
  • [6] THE GROWTH HORMONE-RELEASING ACTIVITY OF A SYNTHETIC HEXAPEPTIDE IN NORMAL MEN AND SHORT STATURED CHILDREN AFTER ORAL-ADMINISTRATION
    BOWERS, CY
    ALSTER, DK
    FRENTZ, JM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (02) : 292 - 298
  • [7] ON THE ACTIONS OF THE GROWTH HORMONE-RELEASING HEXAPEPTIDE, GHRP
    BOWERS, CY
    SARTOR, AO
    REYNOLDS, GA
    BADGER, TM
    [J]. ENDOCRINOLOGY, 1991, 128 (04) : 2027 - 2035
  • [8] GROWTH-HORMONE (GH)-RELEASING PEPTIDE STIMULATES GH RELEASE IN NORMAL MEN AND ACTS SYNERGISTICALLY WITH GH-RELEASING HORMONE
    BOWERS, CY
    REYNOLDS, GA
    DURHAM, D
    BARRERA, CM
    PEZZOLI, SS
    THORNER, MO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) : 975 - 982
  • [9] ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE
    BOWERS, CY
    MOMANY, FA
    REYNOLDS, GA
    HONG, A
    [J]. ENDOCRINOLOGY, 1984, 114 (05) : 1537 - 1545
  • [10] ACTIVITY OF A NOVEL NONPEPTIDYL GROWTH-HORMONE SECRETAGOGUE, L-700,653 IN SWINE
    CHANG, CH
    RICKES, EL
    MARSILIO, F
    MCGUIRE, L
    COSGROVE, S
    TAYLOR, J
    CHEN, H
    FEIGHNER, S
    CLARK, JN
    DEVITA, R
    SCHOEN, W
    WYVRATT, M
    FISHER, M
    SMITH, RG
    HICKEY, GJ
    [J]. ENDOCRINOLOGY, 1995, 136 (03) : 1065 - 1071